The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-((3R,5R,6R)-3-carboxy-3,5,6-trihydroxycyclohex-1-enyl)-1H-1,2,3-triazol-1-yl)benzoic acid ID: ALA3221801
PubChem CID: 90668068
Max Phase: Preclinical
Molecular Formula: C16H15N3O7
Molecular Weight: 361.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cccc(-n2cc(C3=C[C@@](O)(C(=O)O)C[C@@H](O)[C@@H]3O)nn2)c1
Standard InChI: InChI=1S/C16H15N3O7/c20-12-6-16(26,15(24)25)5-10(13(12)21)11-7-19(18-17-11)9-3-1-2-8(4-9)14(22)23/h1-5,7,12-13,20-21,26H,6H2,(H,22,23)(H,24,25)/t12-,13-,16+/m1/s1
Standard InChI Key: CVIDBOLEBIAPKP-IOASZLSFSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
13.3640 -6.0588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1535 -6.8512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9450 -6.6373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6422 -8.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6411 -8.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3491 -9.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0588 -8.8547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0559 -8.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3473 -7.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7640 -7.6243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5118 -7.9538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0563 -7.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6451 -6.6383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8464 -6.8113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8667 -7.4306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2005 -8.1776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0098 -8.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4913 -7.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3422 -6.7676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5270 -7.2142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1565 -5.8432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3422 -9.0081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7211 -8.8394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3497 -10.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6419 -10.4927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0573 -10.4930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
8 10 1 0
15 16 1 0
15 19 2 0
16 17 1 0
17 18 1 0
18 2 1 0
2 19 1 0
12 15 1 0
3 20 1 0
3 21 2 0
17 22 1 1
16 23 1 6
24 25 1 0
24 26 2 0
6 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.31Molecular Weight (Monoisotopic): 361.0910AlogP: -0.71#Rotatable Bonds: 4Polar Surface Area: 166.00Molecular Species: ACIDHBA: 8HBD: 5#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.98CX Basic pKa: ┄CX LogP: -0.33CX LogD: -7.00Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -0.25
References 1. Tran AT, Cergol KM, Britton WJ, Imran Bokhari SA, Ibrahim M, Lapthorn AJ, Payne RJ. (2010) Rapid assembly of potent type II dehydroquinase inhibitors viaClick chemistry, 1 (4): [10.1039/C0MD00097C ]